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Background: Inflammation plays a crucial role in the pathogenesis of in-stent restenosis. Neutrophil-to-lymphocyte ratio (NLR) provides a 
simple method for assessment of inflammatory status and prognosis in patients with coronary artery disease. The aim of the present study was to 
investigate the association of pre-procedural NLR and in stent restenosis with drug eluting stents.
methods: We performed a restrospective analysis of patients who underwent primary percutaneous coronary intervention with a drug eluting stent 
and follow up coronary angiography owing to stable or unstable angina pectoris. Patients were assigned to an instent restenosis group (n=97, mean 
age 63.7 ± 10.9 years, 67% males) and no-instent restenosis group (n=61, mean age 64.8 ± 11.9 years, 55% males).
results: Descriptive analysis between the two groups demonstrated significant association for restenosis among recipients of Sirolimus eluting 
stents (14.4% vs 2%, p 0.012), high density lipoprotein (39.9 ± 12.7 vs 31.6 ± 9.89, p 0.033) and Neutrophil/ Lymphocyte Ratio >4.5 (19.5% vs 
6.6%, p 0.041). Although parameters for absolute total leukocyte count and total neutrophil count were higher in the instent restenosis group, they 
did not meet statistical significance.
conclusion: In conclusion, increased NLR may serve as an inexpensive and easily measurable laboratory variable for predicting in stent restenosis 
among recipients of drug eluting stents with stable and unstable angina pectoris.
Intent Restenosis No instent Restenosis p value
Indication for initial catheterization: Acute Coronary Syndrome 83 (85.5%) 47 (77.4%) 0.985
Time between angiographies (months) 18.8 ± 16.9 22.9 ± 12.4 0.083
Sirolimus (Cypher) 14 (14.4%) 1 (1.6%) 0.012
Zotarilumus (Endeavor) 25 (25.8%) 19 (31.1%) 0.191
Everolimus (Promus) 27 (27.8%) 23 (37.7%) 0.141
Stent length (mm) 22.4 ± 6.18 21.6 ± 6.65 0.470
White Blood Cell count (103/µl) 7.6 ± 2.2 8.7 ± 6.8 0.274
Neutrophils (%) 62.3 ± 11.8 52.5 ± 15.2 0.113
Neutrophil/ Lymphocyte Ratio >4.5 19 (19.5%) 4 (6.6%) 0.041
